Trials / Unknown
UnknownNCT05051605
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Evaluation of the Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective cohort study to evaluate the response to COVID-19 vaccine in liver transplantation patients.
Detailed description
fifty living donor liver transplantation recipients during maintenance immunosuppression phase will be vaccinated against COVID-19 followed by assessment of immune response to the vaccine and further investigation of correlation of immune response to genetic polymorphisms of HLA DRB1(rs2647087) gene and IL-18 (rs187238 and rs917997) gene.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | COVID-19 Vaccine | Severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2)vaccine according to vaccine availability in the Egyptian ministry of health. |
Timeline
- Start date
- 2021-09-15
- Primary completion
- 2023-06-30
- Completion
- 2023-11-30
- First posted
- 2021-09-21
- Last updated
- 2023-02-14
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05051605. Inclusion in this directory is not an endorsement.